The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Advanced or recurrent endometrial cancer (EC) and co-occurring mutations in multiple oncogenic pathways.
Alexandra Leary
No relevant relationships to disclose
Shanna Rajpar
No relevant relationships to disclose
Sandrine Mace
Employment or Leadership Position - Sanofi
Pierre Duvillard
No relevant relationships to disclose
Annie Rey
No relevant relationships to disclose
Sebastien Gouy
No relevant relationships to disclose
Christine Haie-Meder
No relevant relationships to disclose
Patricia Pautier
No relevant relationships to disclose
Coumaran Egile
Employment or Leadership Position - Sanofi
Isabelle Miran
No relevant relationships to disclose
Ludovic Lacroix
No relevant relationships to disclose
Catherine Lhomme
No relevant relationships to disclose